As of close of business last night, Oscar Health Inc.’s stock clocked out at $7.10, down -3.01% from its previous closing price of $7.32. In other words, the price has decreased by -$0.22 from its previous closing price. On the day, 1215274 shares were traded.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Ratios:
To gain a deeper understanding of OSCR’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.78. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.32.
Upgrades & Downgrades
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 when Blackley Richard Scott sold 30,764 shares for $4.88 per share. The transaction valued at 150,156 led to the insider holds 369,521 shares of the business.
Quane Alessandrea C. sold 12,473 shares of OSCR for $60,879 on Mar 06. The EVP, Chief Insurance Officer now owns 188,328 shares after completing the transaction at $4.88 per share. On Mar 02, another insider, Sankaran Sid, who serves as the Interim CFO of the company, sold 110,396 shares for $4.75 each. As a result, the insider received 524,436 and left with 117,452 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OSCR now has a Market Capitalization of 1.53B and an Enterprise Value of 271.92M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.35 while its Price-to-Book (P/B) ratio in mrq is 1.66. Its current Enterprise Value per Revenue stands at 0.06.
Stock Price History:
Over the past 52 weeks, OSCR has reached a high of $8.08, while it has fallen to a 52-week low of $2.05. The 50-Day Moving Average of the stock is 6.09, while the 200-Day Moving Average is calculated to be 4.68.
Shares Statistics:
It appears that OSCR traded 3.58M shares on average per day over the past three months and 1.98M shares per day over the past ten days. A total of 216.91M shares are outstanding, with a floating share count of 142.34M. Insiders hold about 0.40% of the company’s shares, while institutions hold 88.30% stake in the company. Shares short for OSCR as of Apr 27, 2023 were 8.46M with a Short Ratio of 8.46M, compared to 9.54M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 3.87% and a Short% of Float of 5.53%.
Earnings Estimates
As of right now, 3 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.26 for the current quarter, with a high estimate of -$0.21 and a low estimate of -$0.34, while EPS last year was -$0.53. The consensus estimate for the next quarter is -$0.48, with high estimates of -$0.41 and low estimates of -$0.53.
Analysts are recommending an EPS of between -$1.41 and -$1.64 for the fiscal current year, implying an average EPS of -$1.51. EPS for the following year is -$0.53, with 3 analysts recommending between -$0.21 and -$0.73.
Revenue Estimates
In the current quarter, 2 analysts expect revenue to total $1.44B. It ranges from a high estimate of $1.45B to a low estimate of $1.43B. As of the current estimate, Oscar Health Inc.’s year-ago sales were $1.02B, an estimated increase of 41.50% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $1.37B, an increase of 40.40% less than the figure of $41.50% in the same quarter last year. There is a high estimate of $1.41B for the next quarter, whereas the lowest estimate is $1.33B.
A total of 2 analysts have provided revenue estimates for OSCR’s current fiscal year. The highest revenue estimate was $5.7B, while the lowest revenue estimate was $5.5B, resulting in an average revenue estimate of $5.6B. In the same quarter a year ago, actual revenue was $3.96B, up 41.30% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $6.52B in the next fiscal year. The high estimate is $6.54B and the low estimate is $6.5B. The average revenue growth estimate for next year is up 16.30% from the average revenue estimate for this year.
